Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

Arthritis and Rheumatic Disease Specialties, Aventura

Innovative Health Research, Las Vegas

WALLACE, Los Angeles

East Bay Rheumatology Medical, San Leandro

Revmatologie s.r.o., Brno

Revmatologický ústav v Praze, Prague

GHR Mulhouse Sud-Alsace, Mulhouse

CHU de la Réunion, Saint-Denis

Schlosspark-Klinik Berlin, Berlin

Clinic for Rheumatology and Internal Medicine, Freiburg im Breisgau

University of Debrecen Medical Center Department of Clinical Immunology, Debrecen

Mentaház Magánorvosi Központ Kft., Székesfehérvár

CAP Research, Phoenix

Latin Clinical Trial Center, San Juan